Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,174.2
14.4 (0.46%)

 

  • STI Straits Times Index
    3,174.2
    14.4 (0.46%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,563.6
    2.6 (0.17%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,217.0
    154.5 (0.59%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,899.5
    21.4 (0.74%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,300.1
    164.9 (0.71%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,152.1
    39.2 (0.64%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,060.7
    -8.2 (-0.39%)
    Index delayed 20 minutes
  • XAO XAO
    6,791.1
    76.7 (1.14%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 835.5M
  • Value: 956.9M
  • Rise: 173
  • Fall: 112
  • Unch: 542

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Golden Agri-Res0.230+0.015
Rex Intl0.174+0.002
Tritech0.026-0.002
YZJ Shipbldg SGD1.100+0.030
Mapletree NAC Tr1.150-0.010
MDR0.001-
AusGroup^0.030+0.002
UMS0.990+0.040
ComfortDelGro2.400+0.060
Keppel Reit1.250+0.010

World Indices

World Indices
Name Last Change
Nasdaq 8,566.7 +46.0
HSI 26,217.0 +154.5
HSCEI 10,321.8 +67.7
Jakarta 6,152.1 +39.2
Nikkei 225 23,300.1 +164.9
SSE Comp 2,899.5 +21.4
Shanghai A 3,038.2 +22.3
Shanghai B 241.6 +4.0
PSE Comp 0.0
KOSPI 2,060.7 -8.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

WEIGAO GROUP WEIGAO GROUP
Quotes 15 Minutes Delayed. Updated at 05 Dec 2019 16:08
Last (HKD): 9.170 Change: +0.130 High: 9.170 Remarks: -
Change (%): +1.44 Low: 9.040
Open 9.050 Yesterday's Close 9.040
Buy Price 9.160 Sell Price 9.160
Buy Volume ('000) 760 Sell Volume ('000) 712
Cumulative Volume ('000) 11,531.568 Cumulative Value 106,809,449
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.38578 Trailing EPS (HKD) e 0.44735 NAV (HKD) b 3.8912
PE a 23.770 Trailing PE f 20.498 Price / NAV b 2.3566
Dividend (HKD) d 0.114000 Cash In Hand (HKD) g 0.9991 Issued & Paid-up Shares c 4,522,330,000
Dividend Yield (%) d 1.243 Price / Cash In Hand g 9.178 Treasury Shares h -
Beta - 75 Daysi 0.387 R-Squared - 75 Days(%)i 3.28 Market Cap (M) 41,469.766
Beta - 500 Daysi 0.724 R-Squared - 500 Days (%)i 10.67 Enterprise Value (M) 44,119.580
Piotroski F Score 4 Exchange Code 1066 Par Value ( CNY ) 0.10000
52 Weeks Volatility (%) 31.08 6-Month VWAP 8.134 Free Float (%) 50.7
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 09 Aug 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference WEIGAO GROUP HKEx 41,469.766 23.770 20.498 2.3566 1.243
Industry Medical Specialties HKEx 4,937.614 39.638 27.810 2.1023 0.833
Local Peer MICROPORT HKEx 12,273.763 65.486 23.848 3.1526 0.379
Local Peer AK MEDICAL HKEx 9,367.796 54.569 40.076 8.6329 0.389
Local Peer CIRC HKEx 6,493.458 16.976 15.989 1.6018 1.521
Local Peer LIFETECH SCI HKEx 5,778.905 40.289 34.362 3.7274 -
Local Peer YESTAR HEALTH HKEx 3,247.037 10.889 10.256 2.4154 -
Local Peer GOLDEN MEDITECH HKEx 2,333.544 - - 0.5688 -
Local Peer PW MEDTECH HKEx 2,024.332 14.886 12.932 0.3902 -
Local Peer KDL MEDICAL HKEx 1,570.900 - - - -
Local Peer MODERN DENTAL HKEx 1,425.757 16.697 13.342 0.7047 2.288
Local Peer MY MEDICARE HKEx 1,008.295 - - -29.1139 -
Local Peer YUNNAN ENERGY HKEx 804.276 - - 2.8399 -
Local Peer VINCENT MED HKEx 382.590 12.363 12.067 1.0045 2.667
Other Local Peers KELFRED (HKEx), LIFE HEALTHCARE (HKEx), COMBEST HOLD (HKEx), HUAKANG BIOMED (HKEx), CH DEMETER FIN (HKEx)
Global Peer ABBOTT LABORATORIES NYSE 150,547.132 63.981 46.025 4.7316 1.353
Global Peer MEDTRONIC PLC NYSE 150,042.137 32.400 32.136 2.9665 1.859
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 126,568.799 43.080 35.236 4.3117 0.232
Global Peer DANAHER CORP NYSE 105,809.974 39.915 43.523 3.4240 0.424
Global Peer STRYKER CORP NYSE 76,516.128 21.536 22.334 6.2133 0.944
Global Peer BECTON DICKINSON & CO NYSE 69,570.426 - - - -
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,302.207 59.670 51.215 8.6714 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 59,948.198 35.876 54.998 6.1808 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 51,347.848 71.099 66.367 13.4601 -
Global Peer BAXTER INTERNATIONAL INC NYSE 42,085.131 25.914 26.602 5.3872 0.890
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), DEXCOM INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), TELEFLEX INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), COOPER COS INC (NYSE), WATERS CORP (NYSE), HOLOGIC INC (NASDAQ), STERIS PLC (NYSE), DENTSPLY SIRONA INC (NASDAQ), VARIAN MEDICAL SYSTEMS INC (NYSE), INSULET CORPORATION (NASDAQ), BIO RAD LABORATORIES INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), NOVOCURE LTD (NASDAQ), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), HAEMONETICS CORP (NYSE), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), HARTA (Bursa), LIVANOVA PLC (NASDAQ), NUVASIVE INC (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), CANTEL MEDICAL CORP (NYSE), CONMED CORP (NASDAQ), QUIDEL CORP (NASDAQ), Top Glove (SGX), TOPGLOV (Bursa), GLAUKOS CORPORATION (NYSE), EBOS GROUP (ASX), IRHYTHM TECHNOLOGIES INC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), STAAR SURGICAL CO (NASDAQ), AVANOS MEDICAL INC (NYSE), INOGEN INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), INMODE LTD (NASDAQ), NANOSONICS LIMITED (ASX), ATRION CORP (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ATRICURE INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), CRYOLIFE INC (NYSE), CAREDX INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), HESKA CORP (NASDAQ), QUOTIENT LTD (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), AXOGEN INC (NASDAQ), CERUS CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), SURMODICS INC (NASDAQ), CUTERA INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SI BONE INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), SIENTRA INC (NASDAQ), SUPERMX (Bursa), MCP INCOME OPPORTUNITIES TRUST (ASX), VIEWRAY INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), CORMEDIX INC (NYSE American), ZYNEX INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), INVACARE CORP (NYSE), MISONIX INC (NASDAQ), STEREOTAXIS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), CRH MEDICAL CORP (NYSE American), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), VAPOTHERM INC (NYSE), REPRO MEDSYSTEMS INC (NASDAQ), SOLITON INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), INTRICOM CORP (NASDAQ), TELA BIO INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), FONAR CORP (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SOMNOMED LIMITED (ASX), CYTOSORBENTS CORP (NASDAQ), CONFORMIS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), COMPUMEDICS (ASX), PROFOUND MED CORP (NASDAQ), DERMTECH INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), NEURONETICS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), ELECTROMED INC (NYSE American), STRATA SKIN SCIENCES INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), SDI LTD (ASX), SOLENO THERAPEUTICS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), NEPHROS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), ELLEX MEDICAL LASERS LTD (ASX), MRI INTERVENTIONS INC (NYSE American), IMPEDIMED LIMITED (ASX), APOLLO ENDOSURGERY INC (NASDAQ), ONCOCYTE CORP (NYSE American), OVENTUS MEDICAL LTD (ASX), CYCLOPHARM LIMITED (ASX), MOTUS GI HOLDINGS INC (NASDAQ), ELECTROCORE INC (NASDAQ), ALPHA PRO TECH (NYSE American), ENDOLOGIX INC (NASDAQ), Biolidics (SGX), RETRACTABLE TECHNOLOGIES INC (NYSE American), MILESTONE SCIENTIFIC INC (NYSE American), EKSO BIONICS HOLDINGS INC (NASDAQ), DAXOR CORP (NYSE American), IMMUCELL CORP (NASDAQ), ADMEDUS LTD (ASX), ZOSANO PHARMA CORP (NASDAQ), CELSION CORPORATION (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), Yunnan Energy (SGX), PAVMED INC (NASDAQ), IRIDEX CORP (NASDAQ), RESPIRI LTD (ASX), EMVISION MEDICAL DEVICES LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), IMPRESSION HEALTHCARE LIMITED (ASX), BIOMERICA INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), MICRO-X LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), NANOVIBRONIX INC (NASDAQ), NEOVASC INC (NASDAQ), ADVENTA (Bursa), UG Healthcare (SGX), TITAN MEDICAL INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), DARIOHEALTH CORP (NASDAQ), OBJ LIMITED (ASX), RA MEDICAL SYSTEMS INC (NYSE), ALLEGRA ORTHOPAEDICS LIMITED (ASX), BIOLASE INC (NASDAQ), AVINGER INC (NASDAQ), Medtecs Intl (SGX), OBALON THERAPEUTICS INC (NASDAQ), NEUROTROPE INC (NASDAQ), CYANOTECH CORP (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), CARDIEX LTD (ASX), ATOSSA GENETICS INC (NASDAQ), OPTISCAN IMAGING (ASX), USCOM LTD (ASX), DIMERIX LTD (ASX), LKL (Bursa), Annica (SGX), CHECK-CAP LTD (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), ANALYTICA (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), INSPIREMD INC (NYSE American), MICRON SOLUTIONS INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), DYNATRONICS CORP (NASDAQ), DIGIRAD CORP (NASDAQ), STHAI (SET), NEUROMETRIX INC (NASDAQ), ADHERIUM LIMITED (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), METALICITY LIMITED (ASX), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.280
-2.96 %
10 Days 0.066-0.470
-4.19 %
20 Days 0.066-0.060
+0.07 %
Medium Term Return 3 Months 0.066+0.450
+5.92 %
6 Months 0.125+2.320
+35.69 %
1 Year 0.180+2.490
+39.97 %
Long Term Return 2 Years 0.236+3.900
+78.48 %
3 Years 0.340+3.920
+81.14 %
5 Years 0.521+2.900
+54.56 %
Annualised Return Annualised --
+9.10 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 5.730 - 10.240 Change From 1 Year Low +3.440 % Change From 1 Year Low (%) +60.03
Change From 1 Year High -1.070 % Change From 1 Year High (%) -10.45
2 Years Range 4.770 - 10.240 Change From 2 Years Low +4.400 % Change From 2 Years Low (%) +92.24
Change From 2 Years High -1.070 % Change From 2 Years High (%) -10.45
5 Years Range 4.110 - 10.240 Change From 5 Years Low +5.060 % Change From 5 Years Low (%) +123.11
Change From 5 Years High -1.070 % Change From 5 Years High (%) -10.45
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical devices. It operates through the following segments: Single Use Medical Device Products, Orthopedic Products, and Others. The Single Use Medical Device Products segment involves in the production and sale of single use consumables such as infusion sets, syringes, blood transfusion sets, and blood bags. The Orthopedic Products segment includes production and sale of orthopedic products such as platelet segregator, blood plasma catheter, and blood cell segregator. The Others segment consists of finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.

Historical Price Data

Date Open High Low Close Volume VWAP
05 Dec 2019 9.050 9.170 9.040 9.170 11,531,568 9.2624
04 Dec 2019 9.400 9.450 8.990 9.040 10,612,185 9.2130
03 Dec 2019 9.380 9.490 9.290 9.460 7,267,798 9.4397
02 Dec 2019 9.200 9.470 9.160 9.280 4,619,000 9.3839
29 Nov 2019 9.720 9.730 9.320 9.450 8,042,707 9.4233
28 Nov 2019 9.760 9.840 9.620 9.810 5,248,000 9.8580
27 Nov 2019 9.790 9.790 9.470 9.640 6,297,917 9.7412
26 Nov 2019 9.500 9.620 9.370 9.610 33,329,989 9.5813
25 Nov 2019 9.460 9.720 9.400 9.500 5,608,640 9.5252
22 Nov 2019 9.700 9.720 9.520 9.640 5,892,253 9.6065
21 Nov 2019 9.760 9.760 9.350 9.700 9,958,449 9.6377
20 Nov 2019 10.100 10.100 9.750 9.900 7,864,447 9.9222
19 Nov 2019 9.880 10.080 9.600 10.080 9,783,960 9.9669
18 Nov 2019 9.990 10.160 9.630 9.870 9,886,034 9.9018
15 Nov 2019 10.140 10.240 9.940 9.990 9,444,809 10.0697
14 Nov 2019 9.800 10.220 9.660 10.080 16,335,733 10.0914
13 Nov 2019 9.670 9.900 9.540 9.810 15,459,446 9.7594
12 Nov 2019 9.950 9.950 9.550 9.690 15,872,559 9.7090
11 Nov 2019 9.150 9.470 9.110 9.410 18,782,852 9.4095
08 Nov 2019 9.310 9.310 9.150 9.230 5,069,955 9.2000
07 Nov 2019 9.020 9.230 9.020 9.220 5,994,722 9.1623
06 Nov 2019 9.260 9.340 9.020 9.100 8,647,958 9.1980
Summary
Current 2 Weeks
(22 Nov 2019 to 05 Dec 2019)
9.700 9.840 8.990 9.170 98,450,057 -
Previous 2 Weeks
(08 Nov 2019 to 21 Nov 2019)
9.310 9.840 8.990 9.700 118,458,244 -
4 Weeks from
(11 Oct 2019 to 07 Nov 2019)
8.380 9.840 8.240 9.220 146,177,053 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.